AbbVie Q3 2026 revenue rises 10%; raises fiscal 2026 EPS guidance
Third-quarter revenues climbed 10.3% to $17.4 billion; shares rose on the news. The company increased its adjusted earnings per share full-year guidance and announced a 5.2% dividend hike.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed